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We examined the effects of one night of sleep restriction (Sleep-; 2.5 hrs) on 
subsequent 3-km cycling performance and skeletal muscle recovery from heavy exercise 
compared to a full night of rest (Sleep+; 7 hrs). Seven recreational cyclists (n=6 male, 
n=1 female; age = 24.4 ± 7 yrs; height = 170 ± 10 cm; weight = 68 ± 13 kg VO2max = 61.5 
± 4.4 ml/kg/min) completed four simulated 3-km time trials (TT) and six peak isokinetic 
torque trials at different speeds (30 and 120°/sec) under both conditions. The first 
exercise trial (EX1) consisted of baseline testing followed by heavy exercise (60 min 
interval session + resistance exercise) in the evening, while follow-up testing occurring in 
the morning of the next two days (EX2 and EX3) . TT performance and peak torque were 
assessed on the evening of EX1 between 3-5pm and between 8-10am the following 
morning (EX2), while only peak torque was assessed during the same morning time on 
EX3. Magnitude-based inferences were used to evaluate all variables. Sleep- clearly 
impaired average power output (-12.7 ± 1%) and overall time (-3.5 ± 0.39%) of TT 
performance compared to Sleep+, while there was no clear impact of sleep on peak 
torque at either speed. The current study demonstrates the importance of sleep on 
recovery from heavy exercise with potential differences in exercise types, and warrants 








Sleep is a primordial necessity of human life. The absence of sleep is associated 
with negative effects on motor and cognitive performance, as well as decreased 
metabolic, hormonal and immunological function (13). The National Sleep Foundation 
(NSF) recommends that adults sleep between 7 and 9 hours per night (19). However, 
many Americans fall short of these guidelines. A large-scale (n = 1.1 million Americans; 
aged > 30 y) sleep study conducted by the American Cancer Society reported that that 
over half (52%) of the sample population slept less than 7.5 hrs per night, 20 percent slept 
less than 6.5 hrs per night, and 4 percent slept less than 5.5 hrs per night.  Altogether, 76 
percent were obtaining less than 8 hrs of sleep. Similarly, a more recent report indicates 
that subjects self-reported sleeping 6.8 hrs on weekdays, and 7.4 hrs on weekends (17).  
Additionally, the Center for Disease Control and Prevention (CDC) reported that > 30% 
of adults received an average of less than 6 hrs per night in 2005-2007 (42). These studies 
indicate that average sleep duration has decreased over the past few decades and that 
Americans are not meeting NSF recommendations. The lack of sleep among Americans 
is the result of various factors such as medical conditions, light pollution, work 
conditions, anxiety, caffeine intake, and the environment in which one sleeps (3, 9). 
Regardless of the cause, inadequate sleep has a host of behavioral and physiological 
ramifications for all individuals. The effects of insufficient sleep for athletes are of 
particular interest because of the physiological demands of heavy training and peak 
performance. Moreover, this population is particularly susceptible to sleep disruption 





difficulty falling asleep, early waking patterns, and increased stress levels during training 
and near competition (12, 17).  
Sleep disruption can be dissected into two categories: sleep deprivation and sleep 
restriction.  Sleep deprivation is defined as the absence of sleep, while sleep restriction is 
characterized by intermittent waking, early waking and delayed onset of sleep. Several 
studies have detailed the impact that sleep deprivation and restriction have on overall 
athletic performance (5, 28, 30, 31, 35, 37, 39, 44). Although both forms of sleep 
disruption impair performance during periods of rest or light training, the effects are more 
prominent with sleep deprivation. Additionally, the effect of sleep disruption on recovery 
from heavy bouts of exercise has not been well-documented. 
 Most of what is known about sleep disruption has been gathered in the context of 
sleep deprivation and the literature clearly indicates that it can impair performance. Initial 
work, in the early 1980’s, demonstrated that 36 hrs of sleep deprivation reduced VO2max 
by 11% (30). Subsequent research has similarly concluded that sleep deprivation can 
compromise peak physical capacity in activities ranging from sprint trials to several hour 
time trials.  For example, 30 hrs of sleep deprivation reduced 30 min run performance by 
2.9 percent (35).  Additionally, between 30-36 hrs of sleep deprivation reduced Wingate 
and sprint trial performance in separate studies, suggesting that anaerobic function is 
altered following extensive sleep loss (43, 44). However, some studies have shown no 
relationship between sleep deprivation and anaerobic performance (46–48). Collectively, 
these findings suggest that sleep deprivation may negatively influence athletic 





 Though less is known about sleep restriction, there is evidence that it can 
negatively influence various aspects of physiology and athletic performance. While little 
is known about the effects of sleep restriction on aerobic performance, several studies 
reported decreased anaerobic (1, 45) and strength-related components (37, 39). In an 
early study, distance covered in cycle ergometer fixed intensity (75% VO2max) tests was 
not different after 3 hrs of sleep onset restriction, compared to a full night of rest (34). 
Some studies reported impaired Wingate performance following approximately 4 hrs of 
sleep restriction (2, 45), while other studies with similar amount of restriction did not (32, 
45). Additionally, maximal and sub-maximal weight lifting performance decreased 
following 3 consecutive nights of 3 hrs of sleep (39). However, it is important to note that 
all studies where Wingate performance was negatively affected, sleep was restricted at 
the end of the night, while no changes were seen when sleep onset was delayed. Souissi 
and colleagues confirmed this difference by comparing both conditions (45). Their results 
indicated decreased muscular strength and power when sleep was restricted at the end of 
the night, but no differences from baseline when sleep onset was delayed. Therefore, 
athletic performance is likely inhibited following a night of sleep restriction, and timing 
of sleep restriction may be of importance. 
In addition to physical capacity, sleep alteration perturbs a variety of 
physiological variables including growth hormone, testosterone, cortisol, and lactate. 
These variables are widely known to be elevated in the blood following heavy exercise 
and can be affected by sleep deprivation or sleep restriction. As little as 3 hrs of sleep 
restriction led to higher blood lactate levels during a 20-min submaximal exercise, 





sleep loss, increased metabolic stress from heavy exercise, or a combination of the two 
conditions. However, other results have indicated that preceding sleep restriction has no 
effect on blood lactate levels during exercise (29, 44). It was later reported that sleep 
restriction also reduces cortisol levels when sleep is restricted at the end of the night, 
suggesting that timing of sleep restriction plays a role in neuroendocrine function (33). 
Additionally, testosterone and growth hormone were increased after 4.5 hrs of sleep and 
subsequent sprint trials when compared to baseline sleep and exercise, while plasma 
cortisol was not significantly different (2). Further research must be done on these 
markers to determine the effect that sleep deprivation and sleep restriction in combination 
with exercise has on these markers. 
Collectively, it appears that both sleep deprivation and sleep disruption can 
negatively influence performance. It is important to note that all of the aforementioned 
work examined how sleep disruption influences performance and/or physiology after 
several days of rest/light physical activity in preparation for the performance session. 
Virtually nothing is known about how sleep affects recovery from heavy exercise. Skein 
and colleagues examined performance and glycogen levels in athletes after a full night of 
rest compared with 30 hours of sleep deprivation, having subjects perform heavy exercise 
on two consecutive days separated by either sleep condition (43). Maximal voluntary 
contraction of the quadriceps, sprint trials, and muscle glycogen restoration were reduced 
following sleep deprivation, suggesting that recovery processes are sensitive to sleeping 
patterns. Whether or not more practical sleep disruption (i.e. sleep restriction) influences 
recovery from heavy exercise has not been examined. Further, nothing is known about 





purpose of this study is to determine the effects that sleep restriction has on subsequent 







































Aims and Hypotheses 
 
Aim 1: To determine the effects that sleep restriction has on subsequent time trial 
performance and muscle power following heavy exercise, compared to a full night of 
rest. 
Hypothesis 1: Sleep restriction will impair subsequent time trial performance and muscle 
power following heavy exercise, compared to a full night of rest. 
 
Aim 2: To determine the effects that sleep restriction has on perceived muscle soreness 
following heavy exercise, compared to a full night of rest. 
Hypothesis 2: Sleep restriction will increase muscle soreness following heavy exercise, 

















Significance of the Study 
Several studies have detailed the impact that sleep deprivation and restriction 
have on overall athletic performance. Yet little is known about how sleep restriction may 
impact recovery from heavy exercise.   
To our knowledge, only two studies have examined the effects of sleep disruption 
on recovery from exercise. Although this information is valuable for our understanding of 
the important role that sleep has during recovery from exercise, it is of limited practical 
relevance when considering typical sleep patterns. Since athletes are susceptible to 
disrupted sleep patterns, examining the effects that sleep restriction has on recovery from 
heavy exercise is more practical. Discovering these effects may provide coaches and 
athletes the necessary information to properly time heavy exercise, and determine the 
importance of sleep on muscle recovery. This information may also be beneficial to the 
general population in order to properly plan heavy exercise around days when a full night 
of sleep is more likely.  Doing so may prevent muscle soreness, which can lead to 
discomfort and in turn decreased subsequent exercise during recovery days.  Thus, the 
effects of sleep restriction with subsequent heavy exercise on muscle soreness should also 
be examined. Regardless of the question being answered, these questions have practical 















Approximately 10-15 male cyclists, age 18-25, were recruited from James 
Madison University (JMU) and the surrounding area.  Recruitment efforts were focused 
on the JMU Triathlon and Cycling Club teams and local cycling shops. Subjects were 
required to have a VO2max of ≥ 50 ml/kg/min or 4 L/min. Additionally, subjects who 
reported injuries or disordered sleeping, according to the Pittsburgh Sleep Quality Index 
(PSQI), were disqualified. Subjects were provided verbal and written information 
regarding procedures, and a subsequent written informed consent was obtained. All 





 This protocol was designed to examine the influence of sleep restriction on 
recovery from heavy exercise. Subjects completed a preliminary trial, a familiarization 
phase, and 2 experimental phases, each separated by approximately 7 days. The 
familiarization phase and 2 experimental phases consisted of three exercise sessions 
performed on consecutive days (EX1, EX2, and EX3). EX1 included baseline 
performance testing followed by an exercise protocol designed to elicit fatigue. EX2 and 
EX3 were performed the following two mornings and were used to assess recovery from 
EX1.  EX1 and EX2 performed during the experimental phases were separated by either 
a full night of sleep (Sleep+) or a night of sleep restriction (Sleep-). Order of subject 






 Following height (cm) and body weight (kg) measurements, maximal oxygen 
consumption (VO2max) and peak power (Wmax) were obtained on an electronically braked 
cycle ergometer (Velotron, RacerMate, Inc.; Seattle, WA, USA). Following the VO2max 
test, subjects performed a one-repetition maximal effort test on a leg press machine 
(Cybex International, Inc.; Medway, MA). Subjects performed a self-selected warm-up 
for 5 minutes and began the test at an intensity corresponding to a comfortable 60-min 
ride. Intensity was increased by 25 W every 2 minutes until voluntary termination or until 
RPM drop below 50. Wmax was used to determine workloads during the EX trials. Breath 
samples were analyzed for oxygen uptake (VO2), ventilation (VE), and respiratory 
exchange ratio (RER) (Moxus; Pittsburgh, PA, USA) and heart rate was measured using 
a Polar heart rate monitor (Lake Success, NY, USA). Subjects indicated rate of perceived 
exertion by pointing to a Borg (6-20) RPE scale at the end of each stage. 
 
 Familiarization Phase 
 The familiarization phase was identical to the EX phases (detailed below), and 
was used to ensure that subjects can complete EX protocols at the pre-determined 
intensity, and to minimize learning associated error variance during EX trials. Sleep was 
monitored, but not controlled, during this phase. 
 
Exercise Trial 1 (EX1) 
Subjects arrived at the human performance lab between 3-5pm, not having 





rest, muscle soreness was assessed, as detailed below. Subjects then warmed up on a 
treadmill for 5 min at 3.5 mph and 0% grade. Upon completion of the warm-up, subjects 
performed single-leg extensension peak isokinetic dynamometer tests at 120 and 30 
deg/sec (BioDex, Shirley, NY, USA). Following a 10-min rest, subjects performed a 20-
min warm-up (10 min at 50% Wmax followed by 10 min at 60% Wmax) on the cycle 
ergometer. Following the 20 min warm-up, subjects began a 3-km self-paced time trial. 
Subjects were verbally encouraged to give maximal effort prior to beginning the trial. 
After 10 min of rest, subjects performed a 60-min sprint interval session, previously 
detailed by Goh et al. (15). Sprint intervals lasted 2 min at 95% Wmax followed by 2 min 
at 50% Wmax, at a cadence of > 60 rpm. When subjects failed to maintain cadence at 95% 
Wmax, intensity was reduced by 10% in subsequent sprints. Following a 10-min rest 
period, subjects performed 3 sets of 10 repetitions on a leg press at a weight 
corresponding to 80% of their one-repetition max (Cybex International, Inc.; Medway, 
MA). 
 
Experimental Trial 2 (EX2) 
Subjects arrived at the human performance lab between 7-10am, not having 
consumed alcohol, tobacco or caffeine 24 hrs prior to testing. Following 15 min of seated 
rest, muscle soreness was assessed, using the same protocol as EX1. Subjects then 
warmed up on a treadmill for 5 min at 0% grade. Upon completion of the warm-up, 
subjects performed the same peak isokinetic torque protocol used in EX1. Following 10 






Experimental Trial 3 (EX3) 
 Subjects arrived at the human performance lab between 7:00-10:00am, not having 
consumed alcohol, tobacco or caffeine 24 hrs prior to testing. Following 15 min of seated 
rest, muscle soreness was assessed using the same protocol as EX1 and EX2. Subjects 
then warmed up on a treadmill for 5 min at 0% grade. Upon completion of the warm-up, 
subjects performed the same peak isokinetic torque protocol used in EX1 and EX2. 
 
Sleep Restriction 
 Subjects underwent the first set of EX trials separated by either Sleep+ or Sleep-. 
Subjects were then assigned the alternate sleep condition 7 days later. Subjects attempted 
onset of sleep set between 10:00 pm-12:00 am for both conditions, replicating the same 
onset time in both experimental phases. Onset of sleep was measured using both an 
Actigraph accelerometer and the Sleep Cycle smartphone application, which uses motion 
detection to determine approximate sleep onset and wake time. Subjects were instructed 
to set wake time 8 hrs following sleep onset on Sleep+, and 3 hrs following sleep onset 
on Sleep-. 
 
3-km Time Trial Performance 
 3-km cycling time trials were performed on the Velotron ergometer mentioned 










 Peak isokinetic torque was determined using the BioDex dynamometer mentioned 
above (120° and 30°/sec), at the aforementioned times during EX phases. 
 
Muscle Soreness 
 Muscle soreness ratings were obtained using a visual analog scale from 0-100 
mm, with 0 mm indicating no muscle soreness and 100 mm indicating impaired 
movement due to muscle soreness, as detailed by Saunders et al (41).  Soreness ratings 
were obtained upon arrival on EX1, EX2, and EX3 sessions while walking up and down 
a flight of stairs. 
 
Cardiorespiratory Measures 
Heart Rate & Rate of Perceived Exertion (HR & RPE) 
 During EX trials, HR and RPE were recorded after reaching steady-state during 
min 10 and min 20 of the 20-min warm-up preceding the 3-km time trial.  
 
Oxygen Consumption, Ventilation, & Respiratory Exchange Ratio (VO2, VE & RER) 
VO2, VE, and RER were assessed during EX phases using a Moxus metabolic 
cart (Pittsburgh, PA, USA). Breath samples were obtained throughout the 20 min warm-







Physical Activity & Dietary Control 
 Subjects recorded all food and beverage intake for 24 hrs preceding EX1. After 
the initial EX phase, subjects were provided with copies of their dietary records and 
instructed to replicate their dietary habits following EX1 for the second EX phase. 
Subjects reported to all testing after a >4 hr fast. Within 1 hour of completing EX1, 
subjects consumed a predetermined amount of Ensure Shake corresponding to 20-25% of 
daily energy expenditure using the Harris-Benedict equation. Additionally, subjects were 
instructed to refrain from consuming any other macronutrients during the 2 hrs following 
EX1. Subjects recorded all physical activity 72 hrs prior to EX1 in both phases. Subjects 
were instructed to avoid physical activity between EX1 and EX2, and to keep physical 
activity habits consistent between EX phases. 
 
Statistics 
Total time and mean power output (Watts) from each 3-km time trial were used as 
the performance measures. All data was log transformed to diminish the effects of non-
uniformity. Magnitude-based inferences about the data were derived using methods 
described by Hopkins and colleagues (20). For performance, a previously established 
‘smallest worthwhile change’ in performance was used as the threshold value for a 
condition effect (EX1 time trial vs. EX2 time trial) (21). The smallest worthwhile change 
in performance was defined as 0.3 x the within subject variability of select groups of elite 
cyclists across repeated time trials (CV = 1.5% for time and estimated 4.5% for power) 
(21). For all other variables, the threshold value for a substantial treatment effect was 





All data were log transformed to diminish the effects of non-uniformity. 
Magnitude-based inferences about the data were derived using methods described by 
Hopkins and colleagues (20). For performance, a previously established ‘smallest 
worthwhile change’ in performance was used as the threshold value for a condition effect 
(EX1 time trial vs. EX2 time trial) (21). The smallest worthwhile change in performance 
was defined as 0.3 x the within subject variability of select groups of elite cyclists across 
repeated time trials (CV = 1.5% for time and estimated 4.5% for power) (21). For all 
other variables, the threshold value for a substantial treatment effect was defined as 0.2 x 
within-subject standard deviation, under the Sleep+ condition. 
Published spreadsheets (Hopkins, 2006a and b) were then used to determine the 
likelihood of the true treatment effect (of the population) reaching the substantial change 
threshold; these percent likelihoods were classified as: < 1% almost certainly no chance, 
1-5% = very unlikely, 5-25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = 
very likely, and > 99% = almost certain. Clinical inference criteria were used to classify 
the effects of both conditions on performance. Specifically, if the percent chance of the 
effect reaching the substantial change threshold was < 25% and the effect is clear, it was 
classified as ‘trivial’. If the percent chance of the effect reaching the substantial change 
threshold for benefit exceeded 25%, but the chance for harm was > 0.5%, the effect was 
classified as unclear. An exception to the 0.5% chance of harm criterion was made if the 
benefit/harm odds ratio was > 66, in which case the effect was interpreted as clear and an 
inference was assigned.   
Following individual condition analysis, treatment comparison (Sleep- vs Sleep+) 





classification system detailed above was applied, but mechanistic criteria were used. If 
90% confidence intervals include values that exceeded the substantial change threshold 
for both a positive and negative effect, effects were classified as unclear (> 5% chance of 



























Sleep is a primordial necessity of human life. The absence of sleep is associated 
with negative effects on motor and cognitive performance, as well as decreased 
metabolic, hormonal and immunological function (13). The National Sleep Foundation 
recommends adults obtain between 7-9 hours of sleep per night (19). However, a large-
scale sleep study (n=1.1million adults, ≥ 30 years) conducted by the American Cancer 
Society reported that approximately three quarters of Americans (~76%) obtain ≤ 0.5 
hours per night (25). Notwithstanding the causes of sleep loss, inadequate sleep is 
accompanied with a host of behavioral and physiological ramifications.  
 The effects of insufficient sleep for athletes are of particular interest because of 
the psychological and physiological demands of heavy training and peak performance. 
Moreover, this population is particularly susceptible to sleep disruption due to their 
training and competition habits. For instance, athletes have reported difficulty falling 
asleep, early waking patterns, and increased stress levels during training and near 
competition (12, 17).  
 Sleep disruption can be separated into two categories: sleep deprivation (SDEP) 
and sleep restriction (SR).  SDEP is defined as the absence of sleep, while SR is 
characterized by intermittent waking, early waking or delayed onset of sleep. Most of 
what is known about sleep disruption and exercise has been gathered in the context of 





 Although less is known about the effects of SR on performance, SR appears to 
have a negative impact on anaerobic (1, 45) and strength-related performance (37, 39). 
The effect of SR on aerobic performance is unclear due to limited investigation and 
conflicting results. One study reported a detrimental effect on total distance covered in an 
incremental running test to exhaustion (31), while two others showed no difference in 
distance covered during running and cycling to exhaustion (34, 37).  
 Collectively, it appears that SDEP and SR can impair performance, but the 
physiological mechanisms are poorly understood. It is important to note that all 
aforementioned work examined how sleep disruption influences performance after 
several days of rest/light physical activity in preparation for the performance session. 
Virtually nothing is known about the impact of sleep disturbance on recovery from a 
heavy bout of exercise. Skein and colleagues examined performance and glycogen levels 
in athletes after a full night of rest compared to 30 hrs of SDEP, having subjects perform 
heavy exercise separated by either sleep condition (43). Performance and muscle 
glycogen restoration were reduced following SDEP, suggesting that recovery processes 
are sensitive to sleeping patterns. Whether or not more practical sleep disruption (i.e. SR) 
influences recovery from heavy exercise has not been examined in the context of aerobic 
performance. Further, nothing is known about the impact of SR on perceived muscle 
soreness. Therefore, the purpose of this study is to determine the effects that SR has on 















17 male (n=14) and female (n=3) recreationally trained cyclists, age 18-40, were 
enrolled in the study. However, only 8 subjects (n=6 male, n=2 female; age = 24.4 yrs; 
VO2max = 61.5 ± 4.4 ml/kg/min) completed the study, and data from one female subject 
was removed due to sleep compliance issues. The remaining subjects were not retained 
due to scheduling conflicts, training conflicts, and injury (non-study related). Female 
subjects’ experimental trials were planned to coincide with the follicular phase of their 
menstrual cycles by completing trials within days 1-13. Subjects were also screened for 
disordered sleeping in accordance with the Pittsburgh Sleep Quality Index (PSQI). 
Subjects were provided with verbal and written information regarding procedures, and 
subsequent written informed consent was obtained. All procedures were approved by the 




 This protocol was designed to examine the influence of sleep restriction on 
recovery from heavy exercise. Subjects completed a preliminary trial, a familiarization 
phase, and 2 experimental phases, each separated by 11 ± 8 days. The familiarization 
phase and 2 experimental phases consisted of three exercise sessions performed on 
consecutive days (EX1, EX2, and EX3). EX1 consisted of baseline performance testing 
followed by an exercise protocol designed to elicit fatigue. EX2 and EX3 were performed 
the following two mornings and were used to assess recovery from EX1.  EX1 and EX2 





(Sleep+) or a night of sleep restriction (Sleep-). Order of subject assignment to Sleep+ 
and Sleep- was determined using a randomized crossover design.  
 
Preliminary Trial 
 Following height (cm) and body weight (kg) measurements, maximal oxygen 
consumption (VO2max) and peak power (Wmax) were obtained on an electronically braked 
cycle ergometer (Velotron, RacerMate, Inc.; Seattle, WA, USA). Following the VO2max 
test, subjects performed a one-repetition maximum test on a leg press machine (Cybex 
International, Inc.; Medway, MA). The VO2max test consisted of a self-selected warm-up 
for 5 minutes and began at an intensity corresponding to a comfortable 60-min ride. 
Intensity was increased by 25 W every 2 minutes until voluntary termination or until 
RPM fell below 50. Wmax was used to determine workloads during the EX trials. Breath 
samples were analyzed for oxygen uptake (VO2), ventilation (VE), and respiratory 
exchange ratio (RER) (Moxus; Pittsburgh, PA, USA) and heart rate was measured using 
a Polar heart rate monitor (Lake Success, NY, USA).  
 
Familiarization Phase 
 The familiarization phase was identical to the EX phases (detailed below), and 
was used to ensure that subjects could complete EX protocols at the pre-determined 
intensity, and to minimize learning error variance during the experimental trials. Sleep 







Exercise Trial 1 (EX1) 
Subjects arrived at the human performance lab between 3:00 and 5:00 pm, not 
having consumed alcohol, tobacco or caffeine 24 hrs prior to testing. Following 15 min of 
seated rest, heart rate was recorded and muscle soreness was assessed, as detailed below. 
Subjects then warmed up on a treadmill for 5 min at 3.5 mph and 0% grade. Upon 
completion of the warm-up, subjects performed peak isokinetic dynamometer leg 
extension tests at 120° and 30°/sec (BioDex, Shirley, NY, USA). Following a 10-min 
rest, subjects performed a 20-min warm-up (10 min at 50% Wmax followed by 10 min at 
60% Wmax) on the cycle ergometer. Dependent measurements obtained during EX1 are 
described below. Following the 20 min warm-up, subjects began a 3-km self-paced time 
trial. Subjects were verbally encouraged to give maximal effort prior to beginning the 
trial. After 10 min of rest following the 3-km time trial, subjects performed a 60-min 
sprint interval session, as previously detailed by Goh et al. (15). Sprint intervals consisted 
of 2 min at 95% Wmax followed by 2 min at 50% Wmax, at a cadence of ≥60 rpm. When 
subjects failed to maintain cadence at 95% Wmax, intensity was reduced by 10% in 
subsequent sprints. Following a 10-min rest period, subjects performed 3 sets of 10 
repetitions on a leg press at a weight corresponding to 80% of their one-repetition max 
(Cybex International, Inc.; Medway, MA). 
 
Experimental Trial 2 (EX2) 
Subjects arrived at the human performance lab between 7:00 and 10:00am, not 
having consumed alcohol, tobacco or caffeine 36 hrs prior to testing. Following 15 min of 





performed the same peak isokinetic torque protocol, warm-up, and 3-km time trial 
detailed in EX1. 
 
Experimental Trial 3 (EX3) 
 Subjects arrived at the human performance lab between 7:00 and 10:00 am, not 
having consumed alcohol, tobacco or caffeine 60 hrs prior to testing. Subjects then 
warmed up on a treadmill for 5 min at 0% grade following muscle soreness assessment. 
Subjects then performed the same peak isokinetic torque protocol used in EX1 and EX2. 
 
Sleep Restriction 
 Subjects underwent the first set of experimental trials separated by a randomly-
assigned Sleep+ or Sleep-. Subjects were then assigned the alternate sleep condition 7 
days later. Subjects attempted to initiate sleep between 10:00 pm and 12:00 am for both 
conditions, replicating the same onset time in both experimental phases. Mean sleep onset 
and wake times were 10:51 pm (8:40 pm – 12:25 am) and 6:28 am (4 am – 8 am), 
respectively, during Sleep+. Mean onset and wake times for Sleep- were 11:19 pm (10:10 
pm – 12:46 am) and 2:00 am (12:38 am – 3:41 am) during Sleep-. Onset of sleep was 
measured using both an Actigraph accelerometer (Pensacola, FL) and the Sleep Cycle 
smartphone application, which uses motion detection to determine approximate sleep 
onset and wake time. Subjects were instructed to set wake time 8 hrs following sleep 
onset on Sleep+, and 3 hrs following sleep onset on Sleep-. Following awakening on 
Sleep-, subjects immediately reported to the laboratory whereupon an investigator 





until the beginning of EX2 (between 8:00-10:00am), subjects were permitted to engage in 
any sedentary activity that kept them awake. Activities included playing video games, 
watching movies, and reading books. Sleep was not monitored from EX2 to EX3. 
Mean sleep time during Sleep+ was 6.86 ± 0.5 hrs, and 2.47 ± 0.3 hrs during 
Sleep-.  Mean efficiency (sleep time/time in-bed) was 91.3 ± 7% during Sleep+ and 90.2 
± 7% during Sleep-. Subjects awakened 16.4 ± 12 times during Sleep+ and 5 ± 4 times 
during Sleep-.  
 
3-km Time Trial Performance 
 3-km cycling time trials were performed on the cycle ergometer described 





 Peak isokinetic torque for single leg extension was determined using the BioDex 




 Muscle soreness ratings were obtained using a visual analog scale from 0-100 
mm, with 0 mm indicating no muscle soreness and 100 mm indicating impaired 





were obtained upon arrival on EX1, EX2, and EX3 sessions while walking up and down 
a flight of stairs. 
 
Cardiorespiratory Measures 
Heart Rate & Rate of Perceived Exertion (HR & RPE) 
 During EX trials, HR and RPE were recorded at the end of each 10-min stage of 
the 20-min warm-up preceding the 3-km time trial.  
 
Oxygen Consumption, Ventilation, & Respiratory Exchange Ratio (VO2, VE & RER)
 VO2, VE, and RER were assessed during EX phases using a Moxus metabolic 
cart (Pittsburgh, PA, USA). Breath samples were obtained throughout the 20 min warm-
up preceding the 3-km time trials. Minutes 9-10 and 19-20 were averaged and recorded.  
 
Physical Activity & Dietary Control 
 Subjects recorded all food and beverage intake for 24 hrs preceding EX1. After 
the initial EX phase, subjects were provided with copies of their dietary records and 
instructed to replicate their dietary habits following EX1 for the second EX phase. 
Subjects reported to all testing after a > 4 hr fast. Within 1 hour of completing EX1, 
subjects consumed a predetermined amount of Ensure Shake (Abbott Nutrition; 
Columbus, OH) corresponding to 20-25% of daily energy expenditure using the Harris-
Benedict equation. Additionally, subjects were instructed to refrain from consuming any 
other macronutrients during the 2 hrs following EX1. Subjects recorded all physical 









All data were log transformed to diminish the effects of non-uniformity. 
Magnitude-based inferences about the data were derived using methods described by 
Hopkins and colleagues (20). For performance, a previously established ‘smallest 
worthwhile change’ in performance was used as the threshold value for a condition effect 
(EX1 time trial vs. EX2 time trial) (21). The smallest worthwhile change in performance 
was defined as 0.3 x the within subject variability of select groups of elite cyclists across 
repeated time trials (CV = 1.5% for time and estimated 4.5% for power) (21). For all 
other variables, the threshold value for a substantial treatment effect was defined as 0.2 x 
within-subject standard deviation, under the Sleep+ condition. 
Published spreadsheets (Hopkins, 2006a and b) were then used to determine the 
likelihood of the true treatment effect (of the population) reaching the substantial change 
threshold; these percent likelihoods were classified as: < 1% almost certainly no chance, 
1-5% = very unlikely, 5-25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = 
very likely, and > 99% = almost certain. Clinical inference criteria were used to classify 
the effects of both conditions on performance. Specifically, if the percent chance of the 
effect reaching the substantial change threshold was < 25% and the effect is clear, it was 
classified as ‘trivial’. If the percent chance of the effect reaching the substantial change 
threshold for benefit exceeded 25%, but the chance for harm was > 0.5%, the effect was 





benefit/harm odds ratio was > 66, in which case the effect was interpreted as clear and an 
inference was assigned.   
Following individual condition analysis, treatment comparison (Sleep- vs Sleep+) 
outcomes were assessed using the aforementioned published spreadsheets (8). The 
classification system detailed above was applied, but mechanistic criteria were used. If 
90% confidence intervals include values that exceeded the substantial change threshold 
for both a positive and negative effect, effects were classified as unclear (> 5% chance of 





















3-km Time Trial Performance 
Sleep- was detrimental for recovery of 3-km TT performance compared to Sleep+ 
(finishing time – ‘very likely’; mean power output – ‘likely’). Sleep+ ‘possibly’ impaired 
3-km TT time (EX1 vs. EX2, 0.5 ± 2.3%), whereas Sleep- ‘very likely’ impaired TT time 
(4.0 ± 2.2%). Likewise, Sleep+ ‘possibly’ impaired average power output (-1.8 + 6.0%), 
while Sleep- ‘very likely’ impaired average power output (-14.5 + 11.1%). Mean time 
trial performance times are displayed in Fig.1. Mean power outputs, with are displayed in 




EX1 vs. EX2: 
 The effects of sleep condition on peak isokinetic torque at both contraction speeds 
(30°/sec and 120°/sec) were ‘likely trivial’. Sleep+ had a ‘most likely trivial’ effect on 
torque at 30°/sec (-4.0 ± 1.5%), while Sleep- ‘possibly’ decreased torque (-8.1 ± 6.3%). 
Both sleep conditions had a ‘likely trivial’ effect on torque at 120°/sec (Sleep+, -8.1 ± 
4.0%; Sleep-, -7.5 ± 4.7%). Raw data for all muscle recovery variables is displayed in 
Table 1. 
 
EX1 vs. EX3: 
 Sleep condition had a ‘possible’ effect on peak isokinetic torque at both 





30°/sec (Sleep+, -2.3 ± 7.2%; Sleep-, 2.2 ± 7.9%). Sleep+ ‘likely’ impaired peak torque at 




EX1 vs. EX2: 
 Sleep- increased muscle soreness rating compared to Sleep+ (soreness – ‘very 
likely’). Sleep+ ‘likely’ decreased muscle soreness (24.8 ± 16.7%), whereas Sleep- 
‘possibly’ increased soreness (13.6 ± 21.0%). 
 
Cardiorespiratory Measures 
Heart Rate and Rate of Perceived Exertion (HR & RPE) 
 Sleep condition had a ‘possible’ effect on resting HR (EX1 vs EX2 – ‘possibly’; 
EX1 vs EX3 – ‘possibly’). Sleep+ ‘possibly’ decreased resting HR from EX1 to EX2 (4.7 
± 6.1%), whereas Sleep- had a ‘possibly trivial’ effect on resting HR (0.5 ± 10.7%). 
Resting heart rate ‘likely’ decreased under both conditions from EX1 to EX3 (Sleep+, -
9.2 ± 11.3%; Sleep-, -11.5 ± 10.1%). 
 Sleep condition had a ‘possible’ effect on both submaximal- and 3-km TT heart 
rates (Submaximal 20:00 – ‘possible’; 2-km – ‘possible’; 3-km – ‘possible’). 
Submaximal HR was ‘likely’ lower Sleep+ (EX1 vs EX2, -2.5 ± 2.7%), whereas Sleep- 
had a ‘possibly trivial’ effect (-0.8 ± 3.6%). Sleep+ ‘likely’ decreased 2-km HR (-3.2 ± 





‘likely’ decreased 3-km HR (-1.8 ± 1.8%), and Sleep- ‘very likely’ decreased 3-km HR (-
3.4 ± 1.9%). 
 RPE during the 20-min warm-up was ‘possibly’ affected by sleep condition. 
Sleep+ had a ‘possibly trivial’ effect on RPE (EX1 vs EX2, -0.2 ± 3.4%), and Sleep- 
‘possibly’ increased RPE (2.5 ± 5.8%).  
 
Oxygen Consumption, Ventilation, & Respiratory Exchange Ratio (VO2, VE & RER): 
EX1 vs. EX2 
 Sleep condition had no clear meaningful effects on VO2, VE or RER (VO2 – 
‘possibly trivial’; VE – ‘possibly trivial’; RER – ‘possibly’). Both conditions ‘likely’ 
increased VO2 (Sleep+, 4.8 ± 4.2%; Sleep-, 5 ± 5.6%) and had a ‘possibly trivial’ effect 
on VE (Sleep+, 0.9 ± 4.7%; Sleep-, 1.3 ± 5.5%). Sleep+ ‘most likely’ decreased RER by 
4.7 ± 1.8%, whereas Sleep- ‘very likely’ decreased RER by 3.4 ± 2.1%. Raw data for all 














Table 1. Raw data for muscle recovery variables under Sleep+ and Sleep- 




+ 195.5 ± 74.6 187.7 ± 71.6 b 193.6 ± 85.0 




+ 172.3 ± 47.0 157.0 ± 43.0 b 159.2 ± 49.6 
- 168.0 ± 46.3 157.0 ± 49.6 b 165.1 ± 51.0 c 
Muscle Soreness 
(mm) 
+ 9.9 ± 8.0 30.5 ± 17.0 24.9 ± 17.1 
- 11.5 ± 9.3 31.7 ± 21.5 34.5 ± 20.9 a  
Average (± standard deviation) of highest two recorded values of peak isokinetic torque at 30°/sec and 
120°/sec during EX1, EX2, and EX3; Muscle soreness taken while walking up and down stairs prior to 
exercise. Within treatment effects are not included, but are reported in results. (a) ‘Very likely’ increased vs 




































Table 2. Raw data for cardiorespiratory variables under Sleep+ and Sleep- 
Variable Sleep EX1 EX2 EX3 
HRrest  
+ 58 ± 9 60 ± 6 52 ± 5 
- 61 ± 15 57 ± 2 a 53 ± 7 b 
HR20-min  
+ 149 ± 11 146 ± 11  
- 
- 151 ± 11 149 ± 9 b 
HR2-km  
+ 177 ± 14         171 ± 8 
- 
- 178 ± 12 170 ± 13 c 
HR3-km  
+ 183 ± 10 179 ± 10 
- 
- 182 ± 9 176 ± 10 a 
VO2 20-min 
 
+ 2.64 ± 0.4 2.77 ± 0.4 c 
- 
- 2.57 ± 0.4  2.69 ± 0.4 c 
VE20-min 
+ 64.83 ± 9.7 65.68 ± 8.9 c 
- 
- 64.97 ± 10.1 66.16 ± 8.9 c 
RER 
+ 0.89 ± 0.04      0.85 ± 0.03 
- 
- 0.90 ± 0.05      0.87 ± 0.05 b 
Average (± standard deviation) of cardiorespiratory variables at rest, during 20-minute warm-up (20-min), 
and during 3-km TT (2-km, 3-km): Heart Rate (HR) – beats per minute, Oxygen Consumption (VO2) – 
L/min, Ventilation (VE) – L/min, and Respiratory Exchange Ratio (RER). Within treatment effects are not 
included, but are reported in results. (a) ‘Possibly’ decreased vs Sleep+; (b) ‘Possibly’ increased vs Sleep+; 



















(a) ‘Possible’ impairment in performance from EX1 to EX2 under Sleep+. (b) ‘Very likely’ impairment in 
performance from EX1 to EX2 under Sleep-. (c) ‘Very likely’ impairment in performance under Sleep- 







































Figure 2. 3-km average power output (Watts) during EX2 in 0.5-km increments for 
Sleep+ and Sleep- 
 
 
(a) ‘Likely’ improvement in EX2 power output vs Sleep-. (b) ‘Likely’ improvement in EX2 power output vs 
Sleep-. (c) ‘Possible’ improvement in EX2 power output vs Sleep-. (d) ‘Very likely’ improvement in EX2 



















































The purpose of this study was to determine the effects of one night of sleep 
restriction on subsequent 3-km cycling performance and skeletal muscle recovery from 
heavy exercise compared to a full night of rest. The primary finding was that a single 
night of sleep restriction impaired recovery of 3-km cycling performance. This was also 
accompanied by possibly greater skeletal muscle soreness, possibly decreased 2-km and 
3-km HR, and possibly higher RPE during submaximal exercise. Although these 
variables were potentially altered by sleep restriction, the small magnitude of change in 
these variables suggests that other unknown factors may be responsible for the detriment 
in performance.  
 To our knowledge, this is the first study to assess the impact of a single night of 
sleep restriction following heavy exercise. Others have documented the effects of sleep 
restriction on aerobic performance without a previous session of heavy exercise (34, 38), 
with only one finding a reduction in performance (31). The same study reported 
decreased time to exhaustion when sleep was restricted at the beginning of the night, as 
well as a greater detriment to performance when sleep was restricted at the end of the 
night.  Accordingly, the specific type of sleep restriction may explain the mixed 
outcomes in previous literature. Sleep restriction at the end of the night, similar to the 
current study, appears to decrease performance (31), whereas sleep restriction in the 
middle of the night has no clear effect on performance (34, 37). While it is apparent that a 
single night of sleep restriction, particularly early waking, can impair performance the 





heavy exercise. Previous work on this topic has been exclusive to sleep deprivation and 
impact on strength-related components following sleep restriction.  
 In the context of recovery from heavy exercise, sleep deprivation has been 
associated with decreased aerobic performance during a prolonged self-selected pace 
sprint interval session (43). Athletes performed three consecutive days of high-intensity 
intervals accompanied by sleep deprivation lasting 30 hrs. Less distance was covered 
during the final 10-min of sprints, and slower mean sprint times were observed, 
compared to a full night of sleep. Impaired performance was also accompanied by 
negative mood states with no increase in perceived effort, which the authors suspect was 
a result of the self-selected exercise intensity (i.e. lower intensity begets lower RPE). 
Sleep restriction at the beginning of the night for 3 consecutive nights has also been 
associated with declined maximal and submaximal weight-lifting performance in the 
afternoon following the third night, indicating impaired recovery from cumulative sleep 
loss (39). In agreement with the current study, peak strength remained unaltered 
following the first night, suggesting that consecutive nights of sleep loss may be more 
detrimental to maximal strength. However, the exercise protocols and timing of exercise 
drastically varied between the two studies, as well as the form of sleep restriction. 
Independent of recovery, sleep deprivation appears to have a clearly detrimental effect on 
aerobic performance (5, 28, 30, 35). Sleep deprivation and restriction have potentially 
negative effects on maximal strength and anaerobic performance without recovery from 
heavy exercise, although the impact is less clear (44, 46–48).  Additionally, both sleep 
deprivation and restriction have clearly negative psychological implications in a 





 The detrimental effects of sleep restriction at the beginning and end of the night, 
as well as chronic restriction (i.e. 2.5-5 hrs per night for 5 days), on neurocognitive 
performance, motor performance, memory, decision making, and overall mood have been 
well-documented (4, 6, 10, 18, 36, 39).  However, the underlying physiological 
mechanisms behind the negative implications of sleep restriction are intrinsically 
complex, particularly as they relate to sport. It is proposed that cerebral metabolism in 
several regions of the brain is slowed following sleep loss, thereby directly affecting 
cognitive performance (50, 51). Several studies have detailed the negative implications 
this may have on exercise performances ranging from combat simulation to weight lifting 
(11, 26, 36, 39, 53). These implications include, but are not limited to: increased fatigue, 
reaction time, perceived effort, and decreased vigor. Our results indicate a ‘possible’ but 
subtle increase in RPE (n=2 increased RPE). Similarly, the only other known study to 
observe impaired aerobic performance after sleep restriction reported no change in RPE 
during an incremental test to exhaustion (31). However, it is possible that a more precise 
measurement of fatigue, such as the more extensive Profile of Mood States (POMS) 
questionnaire, may be necessary to detect changes following sleep restriction. A more 
comprehensive questionnaire may have revealed whether or not impaired performance 
was affected by potentially negative performance expectations associated with subject 
knowledge of sleep restriction. 
In addition to psychological stress, sleep restriction may also negatively impact 
physiological responses to exercise. Typical exercise responses to sleep restriction 
include, but are not limited to increased heart rate, minute ventilation, and plasma lactate 





metabolic demand and an augmented catecholamine release in response to the stress of 
sleep restriction (7, 14, 30). In contrast, we found no changes in submaximal VO2, 
ventilation, or RER. Furthermore, we found a ‘possible’ decrease in TT heart rate, which 
is in agreement with a recent study indicating increased running time to exhaustion with 
no change in heart rate or perceived exertion (31). It is plausible that the ‘possibly’ 
decreased heart rate was due to effect of heart rate variation from morning to evening, 
since exercising heart rate is decreased in the morning (49, 56). Since these findings 
conflict typical responses, even when accompanied by decreased absolute workload, 
other mechanisms may provide a better explanation for impaired performance following 
sleep loss than changes in VO2, ventilation or RER. 
 Although not measured in the current study, impaired glycogen replenishment 
conceivably explains the effect of sleep restriction on performance. In the aforementioned 
study regarding recovery from 30 hrs sleep deprivation, Skein et al. reported decreased 
muscle glycogen content compared to a full night of sleep (43). Considering sleep 
deprivation also inhibited sprint performance and pacing strategies during the interval 
session, negative alterations in muscle metabolism may lead to decreased performance. 
Training with decreased muscle glycogen content has been associated with decreased 
RER, suggesting decreased glucose metabolism as a possible explanation for impaired 
repeated bouts of high-intensity exercise (23).  Furthermore, several studies have 
indicated impaired brain and skeletal muscle glucose metabolism following sleep loss 
(54, 55, 57). The direct effect of impaired glucose metabolism on exercise has not been 





associated with glucose metabolism impairment could potentially explain impaired 
performance in the current study. 
Our results indicated a ‘very likely’ effect of sleep restriction on muscle soreness. 
While increased muscle soreness may contribute to impaired TT performance, soreness 
did not impact peak strength. Sleep restriction appears to have a ‘trivial’ effect on peak 
isokinetic torque. While some studies have indicated impaired strength-related 
components (39), others are in agreement with our findings (16, 37). Interestingly, 
maximal strength performances appear to be less affected by sleep restriction than 
submaximal exercises (39). Collectively, these data suggest athletes may be able to 
overcome detrimental effects of sleep restriction during high-intensity exercises lasting 
only a few seconds.  
In summary, the results of our study indicate impaired 3-km time trial 
performance following sleep restriction. Although the physiological variables measured 
in the current study did not explain the detriment to performance, the apparent increase in 
subjective muscle soreness and ‘possible’ increase in perceived exertion suggest neural 
fatigue as a plausible source of negative consequences of sleep restriction. While the 
effect of sleep restriction on perceived exertion is unclear, other methods, such as the 
POMS questionnaire, should be considered in further research. Furthermore, future 
research on the effects of glycogen depletion and impaired glucose metabolism following 









Due to the inherent potential for sleep loss leading up to competition, athletes 
should aim to minimize external stressors and distractions that may inhibit sleep duration 
and quality. For instance, athletes may consider arriving to the location of competition 
several days prior to their event, especially when traveling across time zones. 
Additionally, athletes should attempt to minimize noise and light pollution before sleep 
onset, as well as occupational work when possible. Furthermore, athletes should consider 
scheduling heavy training sessions around nights in which greater sleep duration and 
quality are most likely in attempt to optimize recovery from training. Future research is 
needed to confirm the detrimental effects of sleep restriction on varying aerobic 
performances and the underlying physiological consequences. Strategies to overcome the 
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Purpose and Objectives 
 
Sleep is a primordial necessity of human life. The National Sleep Foundation 
recommends that adults sleep between 7 and 9 hours per night (58). However, many 
Americans fall short of these guidelines. A large-scale sleep study conducted by the 
American Cancer Society reported that that over half (52%) of the subjects slept less than 
7.5 hrs and 76 percent were obtaining less than 8 hrs of sleep (17). Inadequate sleep has a 
host of behavior and physiological ramifications. Sleep loss can be categorized as either 
sleep deprivation (SDEP) or sleep restriction (SR). SDEP is the complete absence of 
sleep, while SR involves interrupted sleep cycles through delayed sleep onset, 
intermittent waking, or early waking. 
 
SDEP and SR can decrease glucose metabolism in the brain, increased blood pressure, 
and increase sympathetic nervous system activity (24, 40, 52) – conditions that can 
impair athletic performance. The effects of insufficient sleep for athletes are of particular 
interest because of the physiological demands of heavy training and peak performance. 
Moreover, athletes are particularly susceptible to sleep disruption because of their 
training and competition habits. This includes both difficulty falling asleep and early 
waking patterns, perhaps secondary to elevated stress levels (17).   
 
Several studies have demonstrated the negative effects of SDEP and SR using different 
measures of aerobic, anaerobic, and strength performance (2, 27, 30, 32, 35, 37, 39, 43–
45, 48). In addition to physical capacity, sleep disruption perturbs a variety of 
physiological variables including growth hormone, testosterone, cortisol, and lactate. 
Collectively, it appears that sleep disruption can negatively influence performance. 
Relevant to the proposed investigation, the aforementioned work examined how sleep 
disruption influences performance and/or physiology after several days of light physical 
activity prior to the performance session. Whether or not more practical sleep disruption 





purpose of this study is to determine the effects that SR has on subsequent performance 







8-15 recreationally trained male cyclists will be recruited from James Madison University 
and the greater Harrisonburg/Rockingham County area. Testing will occur in the Human 
Performance Lab in Godwin Hall at James Madison University. Participants will be 
recruited by word-of-mouth, email, and social media. Recruitment of subjects will be 
limited by inclusion criteria based on responses to general health and habits 




To be eligible for study participation, the subject must meet the following criteria: 
  
1) Age: 18-45 years 
2) Sex: Male 
3) Recreational cyclists: cyclists are considered “recreational” if cycling consists of a 
minimum of 30 minutes of cycling exercise, 1-2 day per week, consistently over 
the past 3 months. 
4) Subjects are willing and able to give written informed consent, and to understand, 
participate and comply with the study requirements. 
5) Do not currently smoke cigarettes. 
6) Health: Characterized as “low risk” for exercise complications using criteria from 
the American College of Sports Medicine’s Guidelines for Exercise Testing and 
Prescription (9th Ed., ACSM, 2014; see Appendix B).  Low risk is characterized 
by the ACSM as individuals “who are asymptomatic and meet no more than one 
risk factor threshold” from the list below: 
a) Age: Males ≥ 45 yrs  
b) Family History: Myocardial infarction, coronary revascularization, or sudden 
death before 55 years of age in father or other male first-degree relative, or 
before 65 years of age in mother or other female first-degree relative. 
c) Cigarette Smoking: Current cigarette smoker or those who quit within the 
previous 6 months. 
d) Sedentary Lifestyle: Persons not participating in a regular exercise program or 
not meeting the minimal physical activity recommendations from the U.S. 
Surgeon General’s Report. 
e) Obesity: Body mass index > 30 kg/m2. 
f) Hypertension: Systolic blood pressure ≥ 140 mmHg or diastolic ≥ 90 mmHg, 






g) Dyslipidemia: Low-density lipoprotein (LDL) cholesterol > 130 mg/dl or 
high-density lipoprotein (HDL) < 40 mg/dl, or on lipid-lowering medication.  
If total serum cholesterol is all that is available use > 200 mg/dl rather than 
LDL > 130 mg/dl. 
h) Prediabetes: Impaired fasting glucose = fasting plasma glucose ≥ 100 mg/dL 
confirmed by measurements on at least two separate occasions. 
i) High-serum HDL Cholesterol: This is considered a “negative risk factor”, so 1 
of the above risk factors can be subtracted if HDL > 60 mg/dl. 
 
As recommended by the ACSM, we will use the AHA/ACSM Health/Fitness Facility 
Pre-participation Screening Questionnaire to identify the above criteria (ACSM, 2010, p. 
28; see Appendix B). Before testing is initiated, subjects will be given consent forms to 
read and sign that provide a comprehensive description of the study, the risks and 
benefits associated with the study, and the ways in which confidentiality will be 





This protocol was designed to examine the influence of sleep restriction on recovery from 
heavy exercise. Subjects will complete a preliminary trial, a familiarization phase, and 2 
experimental phases, each separated by approximately 7 days. The familiarization phase 
and 2 experimental phases will consist of two exercise sessions performed on consecutive 
days (EX1 and EX2). EX 1 will include baseline performance testing followed by an 
exercise protocol designed to elicit fatigue. EX 2 will be performed the following 
morning and will be used to assess recovery from EX 1. EX1 and EX2 performed during 
the experimental phases will be will be separated by either a full night of sleep (+) or a 
night of sleep restriction (-). Accordingly, EX1 and EX2 sessions separated by a full 
night of sleep will be referred to as EX1+ and EX2+, whereas EX1 and EX2 sessions 
separated a night of sleep restriction will be referred to as EX1- and EX2-. Order of 
subject assignment to Sleep+ and Sleep- will be determined using a randomized 
crossover design. A questionnaire will also be distributed to screen for health history 
(Appendix E), physical activity habits (Appendix D), and dietary habits (Appendix C). 
The total time commitment should not exceed 12 hours. 
 
Preliminary Trial (n=1, 60 min):  
 
Informed Consent – Before testing is initiated, subjects will be given consent forms to 
read and sign that provide a comprehensive description of the study, the risks and 
benefits associated with the study, and the ways in which confidentiality will be 
maintained (see Informed Consent).     
 
Body Mass and Height - Subjects will have their body weight measured to the nearest 0.5 






VO2max - During this assessment, subjects will perform a graded exercise test to 
determine their maximal oxygen uptake (VO2max). Subjects will ride a cycle ergometer at 
a self-selected workload estimated as “a comfortable, but not easy pace for a 1-hour 
ride”.  Workload will be increased by 25 W every 2 minutes until subjects voluntarily 
request to stop due to fatigue or are unable to continue at a cadence >50 rpm.  Oxygen 
uptake will be assessed at each stage during this test. VO2max will be assessed directly 
from data obtained during the test and used as a descriptive characteristic. 
 
 
Familiarization Phase (n=2 visits on consecutive days, 120 min and 60 min, 
respectively):  
 
The familiarization phase will consist of two consecutive days of exercise trials. 
Procedures will be the same as the experimental trials detailed below. Exceptions include 






Exercise Trial 1 (n=2, 120 min each) 
 
Subjects will arrive at the human performance lab between 3-5pm, not having consumed 
alcohol, tobacco or caffeine 24 hrs prior to testing.  
 
Skeletal Muscle Function – Subjects will rest in a seated position for 15 minutes, after 
which perceived muscle soreness ratings will be obtained using a 0-100mm analog scale 
(taken after walking up and down stairs). Subjects will warm-up for 5 minutes on a 
treadmill (3.5 mph) after which they will perform peak muscle function testing. Peak 
isokinetic concentric muscle force will be assessed following a standardized treadmill 
warm-up (3.5 mph; 5 min). This test will be conducted using a Biodex muscle function 
device (Biodex Medical Systems Inc., Shirley NY). Muscle function will be assessed by 
having subjects push as hard as possible against a shin pad that is connected to an 
electronic device that controls speed of movement through the leg-extension. Isokinetic 
leg dynamometry will consist of two warm-up repetitions followed by two maximal 
exertion isokinetic peak torque measurements at 120 deg/sec. One repetition consists of 
knee extension immediately followed by knee flexion, with 30 seconds of rest between 
each maximal exertion repetitions.  
 
3-km Cycling Time Trial – Immediately following skeletal muscle function testing, 
subjects will perform a 20-min warm-up on a stationary cycle ergometer (Velotron) (10 
min at 60% Wmax followed by 10 min at 70% Wmax). During the warm-up, various 
physiological parameters will be profiled (see below). Subjects will then perform a 3-km 







60-minute Sprint Interval – 10 min following completion of the 3-km time trial, subjects 
will complete 60 min of sprint intervals. Subjects will only perform the 60-min sprint 
interval during EX1. Subjects will pedal at 95% of maximal Watt output (Wmax) for 2 
min followed by 2 min at 50% Wmax. Should subjects fail to maintain a cadence of 50 
rpm at 95% Wmax, subsequent sprints will be dropped by 10% Wmax until cadence is 
maintained.  
 
Resistance Exercise – 10 minutes following the 60-min sprint interval, subjects will 




Exercise Trial 2 (n=2, 60 min each) 
 
Subjects will arrive at the human performance lab between 7-9 am, not having consumed 
alcohol, tobacco, or caffeine 24 hrs prior to testing.  
 
Skeletal Muscle Function – The same muscle soreness ratings described in EX1 will be 
used. Immediately following, subjects will warm-up for 5 minutes on a treadmill (3.5 
mph) after which they will perform peak muscle function testing as described above.  
 
3-km Cycling Time Trial – Immediately following skeletal muscle function testing, 
subjects will perform a 20-min warm-up on a stationary cycle ergometer (Velotron) (10 
min at 60% Wmax followed by 10 min at 70% Wmax) and perform a 3-km computer-
simulated time trial on the cycle ergometer. This will last approximately 4-7 minutes.  
 
 
Submaximal Physiological Markers: 
 
Heart Rate & Rate of Perceived Exertion (HR & RPE) 
During EX trials, HR and RPE will be measured at min 10 and min 20 of the 20-




Glucose & Lactate (GLU & LAC) 
Plasma GLU and LAC will be obtained via finger-stick samples at min 10 and 
min 20 of the warm-up preceding the 3-km time trial. Both variables will be 
assessed using an automated YSI 2300 Stat Plus analyzer (Yellow Springs, OH, 
USA). 
 
Oxygen Consumption, Ventilation, & Respiratory Exchange Ratio (VO2, VE & 
RER) 
VO2, VE, and RER will be assessed during EX phases using a Moxus metabolic 





min warm-up preceding the 3 km time trials. Minutes 7-10 and 17-20 will be 





The first set of EX trials will be separated by either Sleep+ or Sleep-. Subjects will then 
be assigned the alternate sleep condition 7 days later. Subjects will attempt onset of sleep 
set at 11:00 pm for both conditions. Onset of sleep will be measured using both an 
Actigraph accelerometer and a smartphone application that uses motion detection (to be 
determined – subjects will not be asked to incur possible costs).  The accelerometer will 
be worn on the wrist to detect. The application will be set to wake the subjects 7.5 hrs 
following sleep onset on Sleep+, and 3.5 hrs following sleep onset on Sleep-. Sleep will 
be monitored, but not controlled, during the familiarization phase. Upon arrival for EX2, 
sleep data will be reviewed to ensure subjects complied with treatment assignment. 
Should subjects fail to comply, they will be permitted to attempt the phase again after a 
seven-day washout period. Should subjects fail to comply a second time, the subject will 
be excluded from the study.  
 
 
Dietary and Exercise Controls: 
 
Subjects will record all food and beverage intake for 24 hrs preceding EX1. After the 
initial EX phase, subjects will be provided with copies of their dietary records and 
instructed to replicate their dietary habits for the second EX phase. Subjects will report to 
all testing after a >2-hr fast. Subjects will consume Ensure Active High Protein Shake 
within 1 hour of completing EX1. Additionally, subjects will be instructed to refrain from 
consuming any other macronutrients during the 2 hrs following EX1. Subjects will be 
instructed to record all physical activity 72 hrs prior to EX1 in both phases. Subjects will 
also be instructed to avoid physical activity between EX1 and EX2, and to keep physical 






Skeletal Muscle Function: 
 
The risks of BioDex muscle function testing and resistance exercise include soreness 
from exertion 24-48 hours post and potential lightheadedness or loss of consciousness if 
correct form is not utilized.  Participants will be instructed in correct form and breathing 
techniques prior to testing. Expected soreness will be comparable to that typically 
experienced following unaccustomed physical activity (i.e. following a pick-up 









The consequences of a single night of sleep restriction comparable to this investigation 
have not been well documented but include impaired insulin sensitivity, increased 
sleepiness and fatigue, and reduced alertness and constant attentiveness. The latter have 
the potential to impact short-term academic performance, decision-making and tasks such 
as driving ability but these have not been documented.  
 
 
Cardiovascular Testing (3-km Time Trial and VO2max test): 
 
According to the American College of Sports Medicine’s Guidelines for Exercise Testing 
and Prescription, the risk associated with heavy exercise for individuals categorized as 
“low risk” is very minimal, and physician supervision is not necessary.  Any subjects 
who do not meet the ACSM criteria for “low risk” will not be allowed to participate in 
the study. In the unlikely event of cardiac or other complications during exercise, an 
emergency plan is in place. This includes immediate access to a phone to call emergency 
personnel. In addition, at least one of the listed investigators will be present during the 





The risks of blood sampling using venipuncture include possible mild bruising, and the 
risk of transfer of blood-borne pathogens, as well as possible risks of infection or skin 
irritation.  These risks are considered to be minimal, and all safety precautions for 
handing blood samples will be followed according to OSHA protocols, including: 
investigators will wear latex gloves at all times during blood sampling and testing. A 
sharps container lined with a biohazard bag will be used for all sharp objects involved in 
the blood sampling; all other materials (i.e. gloves, gauze pads, etc.) used during the 
sampling will be put in a separate waste disposal unit lined with a biohazard bag. All 
investigators who will be involved in blood draws (and handling of blood) have been 
trained in these phlebotomy techniques, and completed JMU blood-borne pathogen 
training. A total of ~25 milliliters of blood will be obtained throughout the course of the 
study, which is roughly 5% of the amount of blood typically obtained during blood 




Provided that subjects comply with testing protocols, they will be provided with 
information regarding their cardiovascular and strength fitness testing. As a whole, the 
present study may provide useful information for athletes who are particularly susceptible 










No data concerning vulnerable populations (minors, prisoners, pregnant woman, 
neonates, fetuses, cognitively impaired, other protected populations) will be collected 















Data collection will take place immediately following IRB approval until complete data 





Mean power output (Watts) from each 3-km time trial will be used as the performance 
measure. All data will be log transformed to diminish the effects of non-uniformity. 
Magnitude-based inferences about the data were derived using methods described by 
Hopkins and colleagues (Hopkins et al., 2009). For performance, a previously established 
‘smallest worthwhile change’ in performance will be used as the threshold value for a 
condition effect (EX1 time trial vs. EX2 time trial) (Hopkins, 2004). The smallest 
worthwhile change in performance will be defined as 0.3 x the within subject variability 
of select groups of elite cyclists across repeated time trials (CV = 1.5% for time and 
estimated 4.5% for power)(21). For all other variables, the threshold value for a 
substantial treatment effect will be defined as 0.2 x within-subject standard deviation, 
under resting conditions. 
 
Published spreadsheets (Hopkins, 2006a and b) will then be used to determine the 
likelihood of the true treatment effect (of the population) reaching the substantial change 
threshold; these percent likelihoods are classified as: <1% almost certainly no chance, 1-
5% = very unlikely, 5-25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% = 
very likely, and >99% = almost certain. Clinical inference criteria will be used to classify 
the effects of condition on performance. Specifically, if the percent chance of the effect 
reaching the substantial change threshold is <25% and the effect is clear, it will be 
classified as ‘trivial’. If the percent chance of the effect reaching the substantial change 





classified as unclear. An exception to the 0.5% chance of harm criterion will be made if 
the benefit/harm odds ratio is >66, in which case the effect will be interpreted as clear 
and an inference will be assigned.   
 
Separate analyses will be performed on each physiological variable within each condition 
(Sleep- and Sleep+) using the spreadsheet mentioned above (Hopkins 2006b). The 
outcomes from each condition will then be compared using the same spreadsheet 
(Hopkins 2006b). The classification system detailed above will be applied but 
mechanistic criteria will be used such that if 90% confidence intervals include values that 
exceed the substantial change threshold for both a positive and negative effect, effects 
will be classified as unclear (>5% chance of reaching the substantial threshold for both a 





Participation in this research will not be completely anonymous due to the inevitable 
familiarity of the research team with some of the subjects.  However, all subjects will be 
assigned an individual identification number to ensure that the data remains confidential.  
All files will be coded with the identification number. Coding sheets with participants' 
names and corresponding identification numbers along with consent forms will be kept, 
indefinitely, separately in a locked filing cabinet by Dr. Luden separate from the data 
files. All hard copies of data (coded with ID number) will be stored, indefinitely, 
separately in locked file cabinets in the Human Performance Lab.  Electronic data and 
files will be stored, indefinitely, on a password-protected computer, and will only contain 
de-identified information. Only the identification number will be entered into the 
computer when creating data spreadsheets and therefore subject’s names will not be 




Upon request, subjects will receive a summary of their testing, including their VO2max 
data and performance data within four weeks of the completion of data collection and 
analysis. Reports will be sent to the subjects by email upon request. 
 
These data will be presented at regional and national conferences, in peer-reviewed 
exercise science journals, and as pilot data for grant applications. Subjects will not be 
personally identified in any way in any of these presentations or publications.   
 
 
Experience of the Researchers 
 
Nicholas D. Luden, Ph.D. is an Associate Professor of Exercise Physiology. He has 
published >15 peer-reviewed manuscripts in the field of exercise physiology. His primary 
research interests revolve around skeletal muscle function and how it can be optimized 





both basic and applied laboratory experience over the past decade, the majority of which 
has been gained while conducting research on endurance athletes.   
 
Chris Womack, Ph.D. has over twenty years of research experience and has authored or 
co-authored over forty papers in peer-reviewed exercise science journals. He is a Fellow 
of the American College of Sports Medicine, the governing body that establishes 
Guidelines for Exercise Testing and Prescription.   
 
John Chase is a second-year graduate student in Exercise Physiology currently working 
on his Master’s thesis. During his coursework, he has been exposed to numerous research 
techniques used in exercise testing. This is the first study he has conducted, and he will 
be under the supervision of his advisor, Nicholas Luden.  
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